Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

A double-blind controlled field trial of doxycycline and albendazole in combination for the treatment of bancroftian filariasis in India.

Gayen P, Nayak A, Saini P, Mukherjee N, Maitra S, Sarkar P, Sinha Babu SP.

Acta Trop. 2013 Feb;125(2):150-6. doi: 10.1016/j.actatropica.2012.10.011. Epub 2012 Oct 30.

PMID:
23123345
2.

Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine.

Mand S, Pfarr K, Sahoo PK, Satapathy AK, Specht S, Klarmann U, Debrah AY, Ravindran B, Hoerauf A.

Am J Trop Med Hyg. 2009 Oct;81(4):702-11. doi: 10.4269/ajtmh.2009.09-0155.

PMID:
19815891
3.

Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production.

Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, Pfarr KM, Adjei O, Büttner DW.

Med Microbiol Immunol. 2003 Nov;192(4):211-6. Epub 2003 Mar 5.

PMID:
12684759
4.

Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial.

Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, Hoerauf A.

Lancet. 2005 Jun 18-24;365(9477):2116-21.

PMID:
15964448
5.

A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection.

Turner JD, Mand S, Debrah AY, Muehlfeld J, Pfarr K, McGarry HF, Adjei O, Taylor MJ, Hoerauf A.

Clin Infect Dis. 2006 Apr 15;42(8):1081-9. Epub 2006 Mar 14.

PMID:
16575724
6.

Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline.

Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Lawson B, Taylor M, Adjei O, Hoerauf A.

Am J Trop Med Hyg. 2009 Jun;80(6):956-63.

PMID:
19478258
7.
8.

Anti-Wolbachia treatment for lymphatic filariasis.

Stolk WA, de Vlas SJ, Habbema JD.

Lancet. 2005 Jun 18-24;365(9477):2067-8. No abstract available.

PMID:
15964428
10.

A single dose of doxycycline in combination with diethylcarbamazine for treatment of bancroftian filariasis.

Sanprasert V, Sujariyakul A, Nuchprayoon S.

Southeast Asian J Trop Med Public Health. 2010 Jul;41(4):800-12.

PMID:
21073054
11.

Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India.

Kshirsagar NA, Gogtay NJ, Garg BS, Deshmukh PR, Rajgor DD, Kadam VS, Kirodian BG, Ingole NS, Mehendale AM, Fleckenstein L, Karbwang J, Lazdins-Helds JK.

Trans R Soc Trop Med Hyg. 2004 Apr;98(4):205-17. Erratum in: Trans R Soc Trop Med Hyg. 2004 May;98(5):329.

PMID:
15049459
12.

A study on the provocative day test effect of ivermectin and albendazole on nocturnal periodic Wuchereria bancrofti microfilaraemia.

Dunyo SK, Nkrumah FK, Simonsen PE.

Trans R Soc Trop Med Hyg. 1999 Nov-Dec;93(6):608-10.

PMID:
10717746
13.

Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.

Ismail MM, Jayakody RL, Weil GJ, Nirmalan N, Jayasinghe KS, Abeyewickrema W, Rezvi Sheriff MH, Rajaratnam HN, Amarasekera N, de Silva DC, Michalski ML, Dissanaike AS.

Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):94-7.

PMID:
9692166
14.
15.

A randomized trial of doxycycline for Mansonella perstans infection.

Coulibaly YI, Dembele B, Diallo AA, Lipner EM, Doumbia SS, Coulibaly SY, Konate S, Diallo DA, Yalcouye D, Kubofcik J, Doumbo OK, Traore AK, Keita AD, Fay MP, Traore SF, Nutman TB, Klion AD.

N Engl J Med. 2009 Oct 8;361(15):1448-58. doi: 10.1056/NEJMoa0900863.

16.

Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.

Supali T, Djuardi Y, Pfarr KM, Wibowo H, Taylor MJ, Hoerauf A, Houwing-Duistermaat JJ, Yazdanbakhsh M, Sartono E.

Clin Infect Dis. 2008 May 1;46(9):1385-93. doi: 10.1086/586753.

PMID:
18419441
17.

Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.

Beach MJ, Streit TG, Addiss DG, Prospere R, Roberts JM, Lammie PJ.

Am J Trop Med Hyg. 1999 Mar;60(3):479-86.

PMID:
10466981
18.

Filamentation temperature-sensitive protein Z (FtsZ) of Wolbachia, endosymbiont of Wuchereria bancrofti: a potential target for anti-filarial chemotherapy.

Sharma R, Hoti SL, Vasuki V, Sankari T, Meena RL, Das PK.

Acta Trop. 2013 Mar;125(3):330-8. doi: 10.1016/j.actatropica.2012.12.004. Epub 2012 Dec 19.

PMID:
23262214
19.

Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti.

Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Buttner M, Adjei O, Buttner D, Hoerauf A.

Trop Med Int Health. 2007 Dec;12(12):1433-41.

20.

A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis.

El Setouhy M, Ramzy RM, Ahmed ES, Kandil AM, Hussain O, Farid HA, Helmy H, Weil GJ.

Am J Trop Med Hyg. 2004 Feb;70(2):191-6.

PMID:
14993632

Supplemental Content

Support Center